The Deal Pipeline

Abbott to Acquire Action Pharma's Investigational Compound, AP214, in Phase 2b ...
Sacramento Bee
AP214 is in development to prevent acute kidney injury (AKI) associated with major cardiac surgery in patients at increased risk and has further potential in adjacent indications. AP214 is a hormone analogue that targets both systemic inflammation and ...
Abbott buys potential kidney treatment for $110MBusinessWeek
Abbott Buys AP214 Hormone From Action Pharma For $110 MillionFox Business

all 52 news articles »